Our data suggest that higher expressed ICOSL tumor tissues express higher levels of IFN-γ and IL-17, and less IL-10 and IL-4, compared with ICOSL low expressed tumor tissue, indicating that ICOSL promotes Th1 and Th17 response in NPC patients. This evidence concerns the gene IL17A and nasopharyngeal carcinoma.